Beneficial Pharmacological Effects of Levosimendan on Antioxidant Status of Acute Inflammation Induced in Paw of Rat: Involvement in Inflammatory Mediators

Basic and Clinical Pharmacology and Toxicology

Volumn 112, Issue 3, 2013, Pages 156-163

  Karakus, Emre ^a   Halici, Zekai ^b   Albayrak, Abdulmecit ^b   Bayir, Yasin ^a   Aydin, Ali ^a   Unal, Deniz ^a   Cadirci, Elif ^a   Ferah, Irmak ^b   Odaci, Ersan ^c  

^a ATATÜRK UNIVERSITY   (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

^c KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; CARRAGEENAN; ENDOL; GLUTATHIONE; INDOMETACIN; INTERLEUKIN 1; INTERLEUKIN 6; LEVOSIMENDAN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DOSE RESPONSE; DRUG DOSE COMPARISON; ENZYME ACTIVATION; IMMUNOMODULATION; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS INHIBITION; RAT;

ACUTE DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CARRAGEENAN; DISEASE MODELS, ANIMAL; EDEMA; HYDRAZONES; INFLAMMATION MEDIATORS; LOWER EXTREMITY; MALE; PYRIDAZINES; RATS; RATS, WISTAR;

RATTUS;

EID: 84873745459     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12004     Document Type: Article

References (67)

1. Mahat MA, Patil BM. Evaluation of anti-inflammatory activity of methanol extract of Phyllanthus amarus in experimental animal models. Indian J Pharm Sci 2007;69:33-6.
2. Huang SS, Chiu CS, Chen HJ, Hou WC, Sheu MJ, Lin YC, et al. Antinociceptive activities and the mechanisms of anti-inflammation of asiatic Acid in mice. Evid Based Complement Alternat Med 2011;2011:895857.
3. Sosa S, Balick MJ, Arvigo R, Esposito RG, Pizza C, Altinier G, et al. Screening of the topical anti-inflammatory activity of some Central American plants. J Ethnopharmacol 2002;81:211-5.
4. Darland T, Heinricher MM, Grandy DK. Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci 1998;21:215-21.
5. Suleyman H, Halici Z, Hacimuftuoglu A, Gocer F. Role of adrenal gland hormones in antiinflammatory effect of calcium channel blockers. Pharmacol Rep 2006;58:692-9.
6. Albayrak A, Polat B, Cadirci E, Hacimuftuoglu A, Halici Z, Gulapoglu M, et al. Gastric anti-ulcerative and anti-inflammatory activity of metyrosine in rats. Pharmacol Rep 2010;62:113-9.
7. Huang MH, Wang BS, Chiu CS, Amagaya S, Hsieh WT, Huang SS, et al. Antioxidant, antinociceptive, and anti-inflammatory activities of Xanthii Fructus extract. J Ethnopharmacol 2011;135:545-52.
8. Szilagyi S, Pollesello P, Levijoki J, Haikala H, Bak I, Tosaki A, et al. Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone. J Cardiovasc Pharmacol 2005;46:369-76.
9. Gruhn N, Nielsen-Kudsk JE, Theilgaard S, Bang L, Olesen SP, Aldershvile J. Coronary vasorelaxant effect of levosimendan, a new inodilator with calcium-sensitizing properties. J Cardiovasc Pharmacol 1998;31:741-9.
10. De Witt BJ, Ibrahim IN, Bayer E, Fields AM, Richards TA, Banister RE, et al. An analysis of responses to levosimendan in the pulmonary vascular bed of the cat. Anesth Analg 2002;94:1427-33, table of contents.
11. Morelli A, Teboul JL, Maggiore SM, Vieillard-Baron A, Rocco M, Conti G, et al. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med 2006;34:2287-93.
12. Zager RA, Johnson AC, Lund S, Hanson SY, Abrass CK. Levosimendan protects against experimental endotoxemic acute renal failure. Am J Physiol Renal Physiol 2006;290:F1453-62.
13. Lepran I, Pollesello P, Vajda S, Varro A, Papp JG. Preconditioning effects of levosimendan in a rabbit cardiac ischemia-reperfusion model. J Cardiovasc Pharmacol 2006;48:148-52.
14. Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, et al. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure. Am J Cardiol 2006;98:102-6.
15. Morelli A, De Castro S, Teboul JL, Singer M, Rocco M, Conti G, et al. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 2005;31:638-44.
16. Boost KA, Hoegl S, Dolfen A, Czerwonka H, Scheiermann P, Zwissler B, et al. Inhaled levosimendan reduces mortality and release of proinflammatory mediators in a rat model of experimental ventilator-induced lung injury. Crit Care Med 2008;36:1873-9.
17. Parissis JT, Adamopoulos S, Farmakis D, Filippatos G, Paraskevaidis I, Panou F, et al. Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure. Heart 2006;92:1768-72.
18. Oldner A, Konrad D, Weitzberg E, Rudehill A, Rossi P, Wanecek M. Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock. Crit Care Med 2001;29:2185-93.
19. Faivre V, Kaskos H, Callebert J, Losser MR, Milliez P, Bonnin P, et al. Cardiac and renal effects of levosimendan, arginine vasopressin, and norepinephrine in lipopolysaccharide-treated rabbits. Anesthesiology 2005;103:514-21.
20. Haikala H, Hyttilä-Hopponen M, Nissinen E, Ruotsalainen M, Pippuri A, Lönnberg K, inventors; OrionPharma, assignee. Anti-inflammatory agents 2002 May 23.
21. Revermann M, Schloss M, Mieth A, Babelova A, Schroder K, Neofitidou S, et al. Levosimendan attenuates pulmonary vascular remodeling. Intensive Care Med 2011;37:1368-77.
22. Willis AL. Release of histamine, kinin and prostaglandins during carrageenin-induced inflammation in the rat. In: Mantegazza P & Horton EW (eds). Prostaglandins, Peptides and Amines. Academic Press, London, UK, 1969;31-8.
23. Vinegar R, Schreiber W, Hugo R. Biphasic development of carrageenin edema in rats. J Pharmacol Exp Ther 1969;166:96-103.
24. Feldman M, McMahon AT. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity? Ann Intern Med 2000;132:134-43.
25. Suleyman H, Demircan B, Karagoz Y, Oztasan N, Suleyman B. Anti-inflammatory effects of selective COX-2 inhibitors. Pol J Pharmacol 2004;56:775-80.
26. Trikas A, Antoniades C, Latsios G, Vasiliadou K, Karamitros I, Tousoulis D, et al. Long-term effects of levosimendan infusion on inflammatory processes and sFas in patients with severe heart failure. Eur J Heart Fail 2006;8:804-9.
27. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993;119:771-8.
28. Sareila O, Korhonen R, Auvinen H, Hamalainen M, Kankaanranta H, Nissinen E, et al. Effects of levo- and dextrosimendan on NF-kappaB-mediated transcription, iNOS expression and NO production in response to inflammatory stimuli. Br J Pharmacol 2008;155:884-95.
29. Desai M, Gayle DA, Casillas E, Boles J, Ross MG. Early undernutrition attenuates the inflammatory response in adult rat offspring. J Matern Fetal Neonatal Med 2009;22:571-5.
30. Dinarello CA. The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N Engl J Med 2000;343:732-4.
31. Malmberg M, Vahasilta T, Saraste A, Koskenvuo JW, Parkka JP, Leino K, et al. Intracoronary levosimendan during ischemia prevents myocardial apoptosis. Front Physiol 2012;3:17.
32. Soeding PF, Crack PJ, Wright CE, Angus JA, Royse CF. Levosimendan preserves the contractile responsiveness of hypoxic human myocardium via mitochondrial K(ATP) channel and potential pERK 1/2 activation. Eur J Pharmacol 2011;655:59-66.
33. Yasa H, Yakut N, Emrecan B, Ergunes K, Ortac R, Karahan N, et al. Protective effects of levosimendan and iloprost on lung injury induced by limb ischemia-reperfusion: a rabbit model. J Surg Res 2008;147:138-42.
34. Katircioglu SF, Seren M, Parlar AI, Turan NN, Manavbasi Y, Aydog G, et al. Levosimendan effect on spinal cord ischemia-reperfusion injury following aortic clamping. J Card Surg 2008;23:44-8.
35. Kersten JR, Montgomery MW, Pagel PS, Warltier DC. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg 2000;90:5-11.
36. Kopustinskiene DM, Pollesello P, Saris NE. Levosimendan is a mitochondrial K(ATP) channel opener. Eur J Pharmacol 2001;428:311-4.
37. Salvemini D, Wang ZQ, Bourdon DM, Stern MK, Currie MG, Manning PT. Evidence of peroxynitrite involvement in the carrageenan-induced rat paw edema. Eur J Pharmacol 1996;303:217-20.
38. Cuzzocrea S, Zingarelli B, Costantino G, Szabo A, Salzman AL, Caputi AP, et al. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br J Pharmacol 1997;121:1065-74.
39. Tanas S, Odabasoglu F, Halici Z, Cakir A, Aygun H, Aslan A, et al. Evaluation of anti-inflammatory and antioxidant activities of Peltigera rufescens lichen species in acute and chronic inflammation models. J Nat Med 2010;64:42-9.
40. Albayrak Y, Halici Z, Odabasoglu F, Unal D, Keles ON, Malkoc I, et al. The effects of testosterone on intestinal ischemia/reperfusion in rats. J Invest Surg 2011;24:283-91.
41. Yigiter M, Halici Z, Odabasoglu F, Keles ON, Atalay F, Unal B, et al. Growth hormone reduces tissue damage in rat ovaries subjected to torsion and detorsion: biochemical and histopathologic evaluation. Eur J Obstet Gynecol Reprod Biol 2011;157:94-100.
42. Oral A, Odabasoglu F, Halici Z, Keles ON, Unal B, Coskun AK, et al. Protective effects of montelukast on ischemia-reperfusion injury in rat ovaries subjected to torsion and detorsion: biochemical and histopathologic evaluation. Fertil Steril 2011;95:1360-6.
43. Cadirci E, Oral A, Odabasoglu F, Kilic C, Coskun K, Halici Z, et al. Atorvastatin reduces tissue damage in rat ovaries subjected to torsion and detorsion: biochemical and histopathologic evaluation. Naunyn Schmiedebergs Arch Pharmacol 2010;381:455-66.
44. Halici Z, Karaca M, Keles ON, Borekci B, Odabasoglu F, Suleyman H, et al. Protective effects of amlodipine on ischemia-reperfusion injury of rat ovary: biochemical and histopathologic evaluation. Fertil Steril 2008;90:2408-15.
45. Lund-Olesen K, Menander KB. Orgotein: a new anti-inflammatory metalloprotein drug: preliminary evaluation of clinical efficacy and safety in degenerative joint disease. Curr Ther Res Clin Exp 1974;16:706-17.
46. McCord JM, Fridovich I. Superoxide dismutase. An enz-ymic function for erythrocuprein (hemocuprein). J Biol Chem 1969;244:6049-55.
47. 2. Free Radic Biol Med 1999;26:905-18.
48. Bilici D, Akpinar E, Kiziltunc A. Protective effect of melatonin in carrageenan-induced acute local inflammation. Pharmacol Res 2002;46:133-9.
49. Oyanagui Y. Inflammation and superoxide production by macrophages. Agents Actions Suppl 1980;7:174-9.
50. Salvemini D, Mazzon E, Dugo L, Riley DP, Serraino I, Caputi AP, et al. Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403. Br J Pharmacol 2001;132:815-27.
51. Khattab MM. TEMPOL, a membrane-permeable radical scavenger, attenuates peroxynitrite- and superoxide anion-enhanced carrageenan-induced paw edema and hyperalgesia: a key role for superoxide anion. Eur J Pharmacol 2006;548:167-73.
52. Parola M, Curzio M, Negro F, Paradisi L, Torrielli MV. Lipid peroxidation in the rat liver after acute inflammation induced by carrageenan. I. Influence of non-steroidal anti-inflammatory agents. Boll Soc Ital Biol Sper 1981;57:638-44.
53. Leduc C, Gentili ME, Estebe JP, Le Corre P, Moulinoux JP, Ecoffey C. The effect of local anesthetics and amitriptyline on peroxidation in vivo in an inflammatory rat model: preliminary reports. Anesth Analg 2002;95:992-6, table of contents.
54. Wu Y, Zhou C, Li X, Song L, Wu X, Lin W, et al. Evaluation of antiinflammatory activity of the total flavonoids of Laggera pterodonta on acute and chronic inflammation models. Phytother Res 2006;20:585-90.
55. Halici Z, Dengiz GO, Odabasoglu F, Suleyman H, Cadirci E, Halici M. Amiodarone has anti-inflammatory and anti-oxidative properties: an experimental study in rats with carrageenan-induced paw edema. Eur J Pharmacol 2007;566:215-21.
56. Zamfirova R, Tzvetanova E, Alexandrova A. In vivo effects of N/OFQ(1-13)NH2 and its structural analogue [Orn9] N/OFQ(1-13) NH2 on carrageenan-iduced inflammation: rat paw oedema and antioxidant status. Cent Eur J Biol 2009;4:170-8.
57. Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 2003;66:1499-503.
58. Carpenter CT, Price PV, Christman BW. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest 1998;114:1653-9.
59. Davi G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, et al. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 1999;99:224-9.
60. Pratico D, Basili S, Vieri M, Cordova C, Violi F, Fitzgerald GA. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. Am J Respir Crit Care Med 1998;158:1709-14.
61. Lawson JA, Rokach J, FitzGerald GA. Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo. J Biol Chem 1999;274:24441-4.
62. Takahashi K, Nammour TM, Fukunaga M, Ebert J, Morrow JD, Roberts LJ 2nd, et al. Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. J Clin Invest 1992;90:136-41.
63. Pratico D, Smyth EM, Violi F, FitzGerald GA. Local amplification of platelet function by 8-Epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms. J Biol Chem 1996;271:14916-24.
64. Minuz P, Andrioli G, Degan M, Gaino S, Ortolani R, Tommasoli R, et al. The F2-isoprostane 8-epiprostaglandin F2alpha increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO. Arterioscler Thromb Vasc Biol 1998;18:1248-56.
65. Sakamoto M, Takaki E, Yamashita K, Watanabe K, Tabuchi S, Watanabe T, et al. Nonenzymatic derived lipid peroxide, 8-iso-PGF2 alpha, participates in the pathogenesis of delayed cerebral vasospasm in a canine SAH model. Neurol Res 2002;24:301-6.
66. Basu S, Hellberg A, Ulus AT, Westman J, Karacagil S. Biomarkers of free radical injury during spinal cord ischemia. FEBS Lett 2001;508:36-8.
67. Chung HS, Lee YC, Kyung Rhee Y, Lee SY. Consumer acceptance of ginseng food products. J Food Sci 2011;76:S516-22.